Ayrmid Ltd., the parent company of Gamida Cell Inc., a pioneering cell therapy company transforming cells into powerful therapeutics, and RoslinCT, a global leader in cell and gene therapy contract development and manufacturing, today announced the expansion of their strategic partnership to include the execution of a commercial supply agreement to support production of Omisirge® (omidubicel-onlv). Following positive clinical trial results, Omisirge® has received FDA approval for a second indi...

The Mojaloop Foundation and the Central Bank of Liberia (CBL), in collaboration with Singapore-based ThitsaWorks and The AfricaNenda Foundation, today announces the launch of the Liberian Inclusive Instant Payments System (IIPS), a modern real-time interoperable payments platform powered by Mojaloop, the open-source payments infrastructure built to advance digital financial inclusion. IIPS will principally enable mobile money transfers between two Mobile Network Operators, Lone Star Cell MTN an...

Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin (Fluid-PRF).1 This launch represents continued progress in Croma’s mission to provide healthcare professionals state-of-the-art tools for their practice. With its innovative design and optimized separation technology, Exprecell™ enables the efficient preparation of a...